No paralogue variants have been mapped to residue 2787 for RYR1.
RYR1 | KFAEYTHEKWAFDKIQNNWSYGENIDEELK>T<HPMLRPYKTFSEKDKEIYRWPIKESLKAMI | 2817 |
RYR2 | KYAEHSHDKWSMDKLANGWIYGEIYSDSSK>V<QPLMKPYKLLSEKEKEIYRWPIKESLKTML | 2783 |
RYR3 | KYAEHSHDKWACDKSQSGWKYGISLDENVK>T<HPLIRPFKTLTEKEKEIYRWPARESLKTML | 2680 |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.T2787S | c.8360C>G | Conflict | rs35180584 | SIFT: Polyphen: | |
Reports | Other Myopathy | Multiminicore disease in a family susceptible to malignant hyperthermia: histology, in vitro contracture tests, and genetic characterization. Arch Neurol. 2004 61(1):106-13. 14732627 | |||
Other Myopathy | A map of human genome variation from population-scale sequencing. Nature. 2010 467(7319):1061-73. 20981092 | ||||
Other Myopathy | An informatics approach to analyzing the incidentalome. Genet Med. 2013 15(1):36-44. doi: 10.1038/gim.2012.112. 22995991 | ||||
Other Myopathy | Using exome data to identify malignant hyperthermia susceptibility mutations. Anesthesiology. 2013 119(5):1043-53. doi: 10.1097/ALN.0b013e3182a8a8e7. 24195946 | ||||
Other Myopathy | Analysis of the entire ryanodine receptor type 1 and alpha 1 subunit of the dihydropyridine receptor (CACNA1S) coding regions for variants associated with malignant hyperthermia in Australian families. Anaesth Intensive Care. 2015 43(2):157-66. 25735680 |